googlemarker
Open An Account
Secure With Us
Refer a Friend
Trade on Mobile

CIPLA LTD.

NSE : CIPLABSE : 500087ISIN CODE : INE059A01026Industry : Pharmaceuticals & Drugs MCap (Rs. in Mn) : 663188.46 Face Value (Rs.) : 2 House : Cipla
BSE822.3521.05 (+2.63 %)
PREV CLOSE (Rs.) 801.30
OPEN PRICE (Rs.) 804.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 101936
TODAY'S LOW / HIGH (Rs.)803.00 824.95
52 WK LOW / HIGH (Rs.)356.75 869.65
NSE822.4520.7 (+2.58 %)
PREV CLOSE( Rs. ) 801.75
OPEN PRICE (Rs.) 802.50
BID PRICE (QTY) 822.45 (1864)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3791378
TODAY'S LOW / HIGH(Rs.) 802.50 825.40
52 WK LOW / HIGH (Rs.)355.3 864.6
1D 1M 3M 1Y 3Y 5Y
Trade Value (Rs. in Lacs)
830.98
Dividend Yield(%)
0.49
TTM EPS (Rs.)
27.81
P/E Ratio
29.57
Book Value (Rs.)
233.61
Face Value (Rs.)
2
MCap (Rs. in Mn)
663188.46
Price/Earning (TTM)
23.43
Price/Sales (TTM)
5.26
Price/Book (MRQ)
3.52
PAT Margin (%)
17.10
ROCE (%)
18.08
Incorporation Year : 17-08 1935

Management Info :

Y K Hamied - Chairman Umang Vohra - Managing Director

Registered Office :

Address : Cipla House,Peninsula Business Park,Ganpatrao Kadam Marg, Lower Parel,
Mumbai,
Maharashtra-400013

Phone : 022-24826000 / 022-24826951

Website : www.cipla.com

Registrars Details :

K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, Luxembourg, MCX
11Jan Cipla recalling over 5.8 lakh packets
Cipla is recalling over 5.8 lakh packets of a drug for the reduction in..
11Jan Cipla trades higher on the bourses
Cipla is currently trading at Rs. 847.55, up by 9.20 points or 1.10% fro..
06Jan Board Meeting Intimation for Notice O
CIPLA LTD.has informed BSE that the meeting of the Board of Directors of..
QTR Sep 20 ANNUAL 20
Net Profit7456.423181.7
Gross Profit 10176.5 29643.1
Operating Profit 11701.4 36001.4
Net Sales 38078.9 126591.5
Rs. in Millions
Torrent Pharma (BSE)
img  2750.50 (4.32%)
M.Cap (Rs. in Cr)46540.86
Procter&Gamble Healt (BSE)
img  6806.50 (1.38%)
M.Cap (Rs. in Cr)11298.37
Ajanta Pharma (BSE)
img  1793.90 (3.03%)
M.Cap (Rs. in Cr)15522.93
Mercury Laboratories (BSE)
img  646.00 (6.60%)
M.Cap (Rs. in Cr)77.52
PROMOTERS
36.7%
NON-INSTITUTION
23.25%
MUTUAL FUNDS/UTI
15.58%
FI/BANKS/INSURANCE
2.08%
FII
0.01%
GOVERNMENT
0%
Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.....Issued in the interest of investors.  |  No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. |  KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
Dear Client, Pursuant to SEBI regulation, update your KYC details through KRA form with supporting documents at earliest to complete KYC-KRA requirement. If already submitted, kindly ignore. For any information, in this regard, please contact to our KYC Department on 022-66556772/73/74 or email at kyc@satco.co.in.
  • NSE - INZ000198838  | 
  • BSE- INZ000198838  | 
  • MCX- INZ000198838  | 
  • NCDEX- INZ000198838  | 
  • CDSL – IN-DP-CDSL-727-2014  | 
  • PMS - INP000003492  | 
  • RESEARCH – INH000002343
  • © Copyright 2015. SATCO CAPITAL MARKETS LTD. || Designed Developed & Content Powered By Accord Fintech Pvt.Ltd.
VISIT COUNT     1915964